Banzel



Indications and Reactions:

Role Indications Reactions
Primary
Epilepsy 29.6%
Lennox-gastaut Syndrome 21.0%
Constipation 6.2%
Convulsion 6.2%
Nausea 4.9%
Sepsis 4.9%
Acidosis 2.5%
Drug Use For Unknown Indication 2.5%
Hypoxia 2.5%
Infantile Spasms 2.5%
Myoclonic Epilepsy 2.5%
Respiratory Distress 2.5%
Status Epilepticus 2.5%
Vagal Nerve Stimulator Implantation 2.5%
Complex Partial Seizures 1.2%
Menorrhagia 1.2%
Orthostatic Hypotension 1.2%
Osteoporosis 1.2%
Pancreatitis 1.2%
Petit Mal Epilepsy 1.2%
Vomiting 12.5%
Rash 10.4%
Liver Function Test Abnormal 6.3%
Paranoia 6.3%
Psychotic Disorder 6.3%
Sudden Unexplained Death In Epilepsy 6.3%
Agitation 4.2%
Blood Potassium Decreased 4.2%
Convulsion 4.2%
Death 4.2%
Dehydration 4.2%
Headache 4.2%
Lethargy 4.2%
Rash Maculo-papular 4.2%
Somnolence 4.2%
Speech Disorder 4.2%
Weight Decreased 4.2%
Aggression 2.1%
Aphasia 2.1%
Chorea 2.1%
Secondary
Epilepsy 29.4%
Lennox-gastaut Syndrome 19.6%
Constipation 12.7%
Convulsion 4.9%
Nausea 3.9%
Seizures 3.9%
Sepsis 3.9%
Product Used For Unknown Indication 2.9%
Status Epilepticus 2.9%
Acidosis 2.0%
Hypoxia 2.0%
Infantile Spasms 2.0%
Myoclonic Epilepsy 2.0%
Respiratory Distress 2.0%
Urinary Tract Infection 2.0%
Vagal Nerve Stimulator Implantation 2.0%
Drug Use For Unknown Indication 1.0%
Seizure 1.0%
Vomiting 22.4%
Somnolence 10.4%
Death 9.0%
Paranoia 9.0%
Chorea 4.5%
Convulsion 4.5%
Nephrotic Syndrome 4.5%
Psychotic Disorder 4.5%
Speech Disorder 4.5%
Sudden Unexplained Death In Epilepsy 4.5%
Oropharyngeal Pain 3.0%
Product Substitution Issue 3.0%
Rash Maculo-papular 3.0%
Status Epilepticus 3.0%
Weight Decreased 3.0%
Abnormal Behaviour 1.5%
Aphasia 1.5%
Crying 1.5%
Dehydration 1.5%
Dizziness 1.5%
Concomitant
Product Used For Unknown Indication 33.0%
Epilepsy 20.6%
Convulsion 14.6%
Complex Partial Seizures 6.0%
Lennox-gastaut Syndrome 4.8%
Insomnia 2.6%
Anxiety 2.4%
Generalised Oedema 2.2%
Infantile Spasms 2.2%
Attention Deficit/hyperactivity Disorder 1.7%
Sleep Disorder 1.5%
Hypokalaemia 1.4%
Nutritional Supplementation 1.4%
Pyrexia 1.0%
Constipation 0.9%
Upper Respiratory Tract Infection 0.9%
Grand Mal Convulsion 0.7%
Mineral Supplementation 0.7%
Nasal Discomfort 0.7%
Quadriplegia 0.7%
Convulsion 30.4%
Status Epilepticus 14.3%
Dehydration 7.1%
Rash Pruritic 5.4%
Screaming 5.4%
Somnolence 5.4%
Urinary Tract Infection 5.4%
Product Substitution Issue 3.6%
Right Ventricular Hypertrophy 3.6%
Abdominal Pain 1.8%
Abnormal Behaviour 1.8%
Adverse Event 1.8%
Aggression 1.8%
Atonic Seizures 1.8%
Coagulation Time Prolonged 1.8%
Crying 1.8%
Dizziness 1.8%
Drug Dose Omission 1.8%
Drug Effect Decreased 1.8%
Drug Ineffective 1.8%